ACM
GH icon

ADAR1 Capital Management’s Guardant Health GH Stock Holding History

ADAR1 Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$924K – 306
2026
Q1 		$924K Buy
10,000
+3,000
+43% +$301K 0.05% 164
2025
Q4 		$715K Buy
7,000
+1,000
+17% +$89.5K 0.05% 163
2025
Q3 		$375K Buy
+6,000
New +$326K 0.04% 154
2024
Q3 		– Sell
-34,000
Closed -$982K – 303
2024
Q2 		$982K Buy
34,000
+17,000
+100% +$396K 0.19% 65
2024
Q1 		$351K Buy
+17,000
New +$364K 0.08% 96

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ADAR1 Capital Management's GH Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Guardant Health (GH) in Q2 2026, closing a stake of 10,000 shares — an estimated $924K sold.

ADAR1 Capital Management first reported a position in GH in Q1 2024 and held it in 5 quarters. The position peaked at $982K in Q2 2024. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 10,000 Guardant Health shares in Q2 2026, an estimated $924K.
  • ADAR1 Capital Management first reported a position in Guardant Health in Q1 2024 and held it in 5 quarters.
  • ADAR1 Capital Management's Guardant Health position peaked at $982K in Q2 2024.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.